{Reference Type}: Published Erratum
{Title}: Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.
{Author}: Mainz JG;Zagoya C;Polte L;Naehrlich L;Sasse L;Eickmeier O;Smaczny C;Barucha A;Bechinger L;Duckstein F;Kurzidim L;Eschenhagen P;Caley L;Peckham D;Schwarz C;
{Journal}: Front Pharmacol
{Volume}: 14
{Issue}: 0
{Year}: 2023
{Factor}: 5.988
{DOI}: 10.3389/fphar.2023.1207356
{Abstract}: [This corrects the article DOI: 10.3389/fphar.2022.877118.].